Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Endonovo Therapeutics (ENDV) Shares Issued (2018 - 2023)

Endonovo Therapeutics has reported Shares Issued over the past 7 years, most recently at $3765.0 for Q3 2023.

  • Quarterly results put Shares Issued at $3765.0 for Q3 2023, changed N/A from a year ago — trailing twelve months through Sep 2023 was $256765.0 (changed N/A YoY), and the annual figure for FY2022 was $142000.0, up 12.7%.
  • Shares Issued for Q3 2023 was $3765.0 at Endonovo Therapeutics, down from $46000.0 in the prior quarter.
  • Over the last five years, Shares Issued for ENDV hit a ceiling of $207000.0 in Q1 2023 and a floor of $3765.0 in Q3 2023.
  • Median Shares Issued over the past 3 years was $39773.5 (2019), compared with a mean of $68888.5.
  • Peak annual rise in Shares Issued hit 288.95% in 2019, while the deepest fall reached 54.07% in 2019.
  • Endonovo Therapeutics' Shares Issued stood at $97237.0 in 2019, then increased by 29.58% to $126000.0 in 2021, then crashed by 97.01% to $3765.0 in 2023.
  • The last three reported values for Shares Issued were $3765.0 (Q3 2023), $46000.0 (Q2 2023), and $207000.0 (Q1 2023) per Business Quant data.